Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply

Willemijn J Jansen; Rik Ossenkoppele; Pieter Jelle Visser

doi:10.1001/jama.2015.9719

Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply

Willemijn J Jansen^*, Rik Ossenkoppele, Pieter Jelle Visser

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1177-8
Number of pages	2
Journal	JAMA-Journal of the American Medical Association
Volume	314
Issue number	11
DOIs	https://doi.org/10.1001/jama.2015.9719
Publication status	Published - 15 Sept 2015

Keywords

Amyloid beta-Peptides
Apolipoprotein E4
Brain
Female
Humans
Male
Mild Cognitive Impairment

Access to Document

10.1001/jama.2015.9719

Cite this

@article{b2819eba43304e808cfeee71a61d7f6e,

title = "Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply",

keywords = "Amyloid beta-Peptides, Apolipoprotein E4, Brain, Female, Humans, Male, Mild Cognitive Impairment",

author = "Jansen, {Willemijn J} and Rik Ossenkoppele and Visser, {Pieter Jelle}",

year = "2015",

month = sep,

day = "15",

doi = "10.1001/jama.2015.9719",

language = "English",

volume = "314",

pages = "1177--8",

journal = "JAMA-Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply

AU - Jansen, Willemijn J

AU - Ossenkoppele, Rik

AU - Visser, Pieter Jelle

PY - 2015/9/15

Y1 - 2015/9/15

KW - Amyloid beta-Peptides

KW - Apolipoprotein E4

KW - Brain

KW - Female

KW - Humans

KW - Male

KW - Mild Cognitive Impairment

U2 - 10.1001/jama.2015.9719

DO - 10.1001/jama.2015.9719

M3 - Article

C2 - 26372591

SN - 0098-7484

VL - 314

SP - 1177

EP - 1178

JO - JAMA-Journal of the American Medical Association

JF - JAMA-Journal of the American Medical Association

IS - 11

ER -